Literature DB >> 26194651

[Acute non-allergic angioedema. Rare cause for intensive care unit admission].

V van der Heide1, T Woehrle, M Ripperger, V Huge.   

Abstract

Angiotensin-converting enzyme (ACE) inhibitor-induced angioedema usually follows an uneventful clinical course; however, if upper airway structures are involved, life-threatening complications may develop. Thus, affected patients should be carefully monitored in an intensive care unit and, if need be, the airway has to be secured early on. This case report discusses diagnostic and therapeutic approaches in a patient with suspected ACE inhibitor-induced angioedema, who had initially been admitted for neoadjuvant radiochemotherapy of rectal cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26194651     DOI: 10.1007/s00101-015-0055-1

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  11 in total

Review 1.  Angioedema: etiology, pathophysiology, current and emerging therapies.

Authors:  Lawrence M Lewis
Journal:  J Emerg Med       Date:  2013-08-29       Impact factor: 1.484

2.  Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.

Authors:  Murat Bas; Jens Greve; Klaus Stelter; Henning Bier; Thomas Stark; Thomas K Hoffmann; Georg Kojda
Journal:  Ann Emerg Med       Date:  2010-05-05       Impact factor: 5.721

3.  A randomized trial of icatibant in ACE-inhibitor-induced angioedema.

Authors:  Murat Baş; Jens Greve; Klaus Stelter; Miriam Havel; Ulrich Strassen; Nicole Rotter; Johannes Veit; Beate Schossow; Alexander Hapfelmeier; Victoria Kehl; Georg Kojda; Thomas K Hoffmann
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

Review 4.  Acute angioedema: recognition and management in the emergency department.

Authors:  Thiagarajan Jaiganesh; Martin Wiese; John Hollingsworth; Chris Hughan; Mohamed Kamara; Philip Wood; Claire Bethune
Journal:  Eur J Emerg Med       Date:  2013-02       Impact factor: 2.799

Review 5.  Renin-angiotensin system inhibitors and angioedema: anesthetic implications.

Authors:  Ljuba Stojiljkovic
Journal:  Curr Opin Anaesthesiol       Date:  2012-06       Impact factor: 2.706

6.  Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors.

Authors:  Harikrishna Makani; Franz H Messerli; Jorge Romero; Omar Wever-Pinzon; Aleksander Korniyenko; Ronaldo Sevilla Berrios; Sripal Bangalore
Journal:  Am J Cardiol       Date:  2012-04-20       Impact factor: 2.778

Review 7.  Angiotensin-converting enzyme inhibitor-induced angioedema--a dangerous new epidemic.

Authors:  Eva R Rasmussen; Kristianna Mey; Anette Bygum
Journal:  Acta Derm Venereol       Date:  2014-05       Impact factor: 4.437

Review 8.  Angiotensin-converting enzyme inhibitor-induced angioedema.

Authors:  Shira Bezalel; Keren Mahlab-Guri; Ilan Asher; Ben Werner; Zev Moshe Sthoeger
Journal:  Am J Med       Date:  2014-07-21       Impact factor: 4.965

9.  Angioedema deaths in the United States, 1979-2010.

Authors:  Susan J Kim; Jordan C Brooks; Javed Sheikh; Michael S Kaplan; Bruce J Goldberg
Journal:  Ann Allergy Asthma Immunol       Date:  2014-10-03       Impact factor: 6.347

Review 10.  Angioedema in the emergency department: an evidence-based review.

Authors:  R Gentry Wilkerson
Journal:  Emerg Med Pract       Date:  2012-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.